Effects of risperidone on behavioral and psychological symptoms associated with dementia in clinical practice

International Psychogeriatrics

Volumn 17, Issue 4, 2005, Pages 605-616

  Kurz, Alexander ^a   Schwalen, Susanne ^b   Schnitt, Andreas ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b JANSSEN CILAG GMBH   (Germany)

Author keywords

Atypical antipsychotic; Behavioral and psychological symptoms; Dementia; Neuroleptics; Sleep wake cycle disturbances

Indexed keywords

HALOPERIDOL; MELPERONE; PIPAMPERONE; PLACEBO; PSYCHOTROPIC AGENT; RISPERIDONE;

ADULT; AGED; AGGRESSION; AGITATION; ARTICLE; BEHAVIOR DISORDER; CARDIOVASCULAR DISEASE; CAREGIVER; CEREBROVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELUSION; DEMENTIA; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE EXACERBATION; DIZZINESS; DRUG EFFICACY; DRUG FATALITY; EXTRAPYRAMIDAL SYNDROME; FALLING; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; PHYSICIAN; PSYCHOSIS; PSYCHOSOCIAL WITHDRAWAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESPIRATORY TRACT DISEASE; SEDATION; SIDE EFFECT; SLEEP DISORDER; SLEEP WAKING CYCLE; TREATMENT FAILURE;

AGED; AGGRESSION; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; DELUSIONS; DEMENTIA; FEMALE; HUMANS; MALE; PREVALENCE; PROSPECTIVE STUDIES; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS; RISPERIDONE; SLEEP DISORDERS, CIRCADIAN RHYTHM; SOCIAL ALIENATION;

EID: 28744453408     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610205002279     Document Type: Article

References (31)

1. Alexopoulos, G. S., Streim, J., Carpenter, D. and Docherty, J. P.; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients (2004). Antipsychotic agents in older patients. Journal of Clinical Psychiatry, 65 (Suppl. 2), 5-99.
2. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington D.C.: American Psychiatric Association.
3. Ancoli-Israel, S., Martin, J. L., Kripke, D. F., Marler, M. and Klauber, M. R. (2002). Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. Journal of the American Geriatrics Society, 50, 282-289.
4. Brodaty, H. et al. (2001). Psychosis, depression and behavioral disturbances in Sydney nursing home residents: prevalence and predictors. International Journal of Geriatric Psychiatry, 16, 504-512.
5. Brodaty, H. et al. (2003). A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. Journal of Clinical Psychiatry, 64, 134-143.
6. Chan, W. C., Lam, L. C., Choy, C. N., Leung, V. P., Li, S. W. and Chiu, H. F. (2001). A double-blind randomized comparison of risperidone and haloperidol in the treatment of behavioral and psychological symptoms in Chinese dementia patients. International Journal of Geriatric Psychiatry, 16, 1156-1162.
7. De Deyn, P. P. and Katz, I. R. (2000). Control of aggression and agitation in patients with dementia: efficacy and safety of risperidone. International Journal of Geriatric Psychiatry, 15 (Suppl. 1), S14-S22.
8. De Deyn, P. P. et al. (1999). A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology, 53, 946-955.
9. Donaldson, C., Tarrier, N. and Burns, A. (1997) The impact of the symptoms of dementia on caregivers. British Journal of Psychiatry, 170, 62-68.
10. Dursun, S. M., Patel, J. K., Burke, J. G. and Reveley, M. A. (1999). Effect of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study. Journal of Psychiatry and Neuroscience, 24, 333-337.
11. Finkel, S. I., Costa e Silva, J., Cohen, G., Miller, S. and Sartorius, N. (1996) Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. International Psychogeriatrics, 8 (Suppl. 3), 497-500.
12. Goldberg, R. J. and Goldberg, J. (1997). Risperidone for dementia-related disturbed behavior in nursing home residents: a clinical experience. International Psychogeriatrics, 9, 65-68.
13. Greenspan, A., Eerdekens, M. and Mahmoud, R. (2003). Risk of cerebrovascular adverse events, including mortality, with risperidone in elderly patients. International Psychogeriatrics, 15 (Suppl. 2), 261-262.
14. Haupt, M., Kurz, A. and Janner, M. (2000). A 2-year follow-up of behavioral and psychological symptoms in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 11, 147-152.
15. Herrmann, N., Mamdani, M. and Lanctot, K. L. (2004). Atypical antipsychotics and risk of cerebrovascular accidents. American Journal of Psychiatry, 161, 1113-1115.
16. Jeste, D. V., Lacro, J. P., Palmer, B., Rockwell, E., Harris, M. J. and Caligiuri, M. P. (1999). Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients. American Journal of Psychiatry, 156, 309-311.
17. Katz, I. R., Jeste, D. V., Mintzer, J. E., Clyde, C., Napolitano, J. and Brecher, M. (1999). Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Journal of Clinical Psychiatry, 60, 107-115.
18. Klein, D. A. et al. (1999). Wandering behavior in community-residing persons with dementia. International Journal of Geriatric Psychiatry, 14, 272-279.
19. Kozma, C., Engelhart, L., Long, S., Greenspan, A., Mahmoud, R. and Baser, O. (2004). Absence of risperidone-related increased stroke risk among dementia patients. Poster presented at the American Psychiatric Association (APA) Annual Meeting, 1-6 May, 2004, New York, N.Y.
20. McCurry, S. M. et al. (1999). Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients. Journal of Geriatric Psychiatry and Neurology, 12, 53-59.
21. McCurry, S. M., Reynolds, C. F., Ancoli-Israel, S., Teri, L. and Vitiello, M. V. (2000). Treatment of sleep disturbance in Alzheimer's disease. Sleep Medicine Review, 4, 603-628.
22. Mega, M. S., Cummings, J. L., Fiorello, T. and Gornbein, J. (1996). The spectrum of behavioral changes in Alzheimer's disease. Neurology, 46, 130-135.
23. Ritchie, K. (1996). Behavioral disturbances of dementia in ambulatory care settings. International Psychogeriatrics, 8 (Suppl. 3), 439-442.
24. Schneider, L. S., Pollock, V. E. and Lyness, S. A. (1990). A metaanalysis of controlled trials of neuroleptic treatment in dementia. Journal of the American Geriatrics Society, 38, 553-563.
25. Schwalen, S. and Kurz, A. (2002). Risperidone for the treatment of behavioral disorders in dementia. Nervenheilkunde, 21, 208-213.
26. Schweitzer, P. K. (2000). Drugs that disturb sleep and wakefulness. In M. H. Kryger, T. Roth and W. C. Dement (Eds.) Principles and Practice of Sleep Medicine (3rd ed., pp. 441-462). Philadelphia, PA: W. B. Saunders Company.
27. Small, G. W. et al. (1997). Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. Journal of the American Medical Association, 278, 1363-1371.
28. Steele, C., Rovner, B., Chase, G. A. and Folstein, M. (1990). Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. American Journal of Psychiatry, 147, 1049-1051.
29. Vitiello, M. V. and Borson, S. (2001). Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment. CNS Drugs, 15, 777-796.
30. Wooltorton, E. (2004). Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. Canadian Medical Association Journal, 167, 1269-1270.
31. Zaudig, M. (2000). A risk-benefit assessment of risperidone for the treatment of behavioral and psychological symptoms in dementia. Drug Safety, 23, 183-195.